UpCoin Media
Back

IKT

Inhibikase Therapeutics, Inc.

Inhibikase Therapeutics is a clinical-stage pharmaceutical company that develops small molecule kinase inhibitor therapeutics to treat pulmonary arterial hypertension and other infectious or cardiopulmonary diseases.

2026 Price Target

$6.00

Average analyst target

0 followers

Currency

Monetary values are shown in your selected currency.

Stock Movement

Jul 29Aug 4Aug 10Aug 14Aug 20Aug 26$2.16$2.25$2.34$2.43$2.52

Profit Simulator

Friday, August 28

Low

$2.38

High

$2.47

Cost of Shares

—

Simulated Profit

—

Simulated results compare the selected period's low and high and do not represent an actual trade. Fees, taxes, slippage, and the ability to execute at exact prices are not included.

Community-Reported Results

Reported Profit

$0

0 profit reports

Reported Loss

$0

0 loss reports

Net Reported

$0

0 total reports

Community Outlook

No community outlook yet.

Be the first to vote when a poll becomes available.

0Followers0Active Polls3Recent Posts$0Reported Net
Bearish
UpCoin Media@UpCoinMedia · 2d

IKT Stock Closes at $2.41 In the Middle of Today's Range

Open: $2.48 High: $2.48 Low: $2.37 Close: $2.41 Why it matters: IKT finished in the middle of today's range.

#MarketClose#PennyStock
Low
UpCoin Media@UpCoinMedia · 2d

IKT Stock Falls to New Session Low of $2.40

IKT is trading lower today at $2.40 (-2.8%).

#MarketAlert
UpCoin Media@UpCoinMedia · 2d

IKT Stock Opens at $2.49

IKT opened today's regular trading session at $2.49, compared with its previous close of $2.47. Opening difference: +0.8% Why it matters: The stock began trading 0.8% above its previous close.

#MarketOpen#PennyStocks

Community sentiment and reported results reflect voluntary member input and should not be interpreted as investment advice or verified performance.